WHO ARE WE?
We are an Australian propriety company limited by shares.
We discover, develop and commercialise novel fibroblast growth factors for applications in hair regrow for humans, and wound healing pharmaceuticals for human and veterinary markets.
Our lead product, bFGF is a large molecule for the treatment of androgenetic alopecia in humans with applications for wound healing across various species.
The simultaneous development of products for both the vet and human markets enables validation of technology and reduces risks of drugs for human development, while generating early revenues.
Latest Company Announcement
London Calling
Appointment of KS Capital as Lead Manager
August 2022 shareholder update
OUR SCIENCE
ReGen Factor has developed first to market technology to produce bio-identical and cost effective Fibroblast growth factors (FGFs) which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration and differentiation. The ReGen Factor scientific team have discovered a way to produce bFGF at less than 10% of the current production cost.
PIPELINE & CLINICAL TRIALS
ReGen Factor aims to establish PepFactor Scalp as the world leading treatment for Adrogenous genetic Alopecia (AGA) in both men and women.
ReGen Factor has completed their initial cosmetic trials on the efficacy and safety of PepFactor Scalp
treatments for the treatment of androgenic alopecia with no adverse reactions reported.
MARKET SHARE
The global alopecia market is estimated at USD $2.6 billion in 2019 and is expected to reach USD 14.2 billion by 2028.
The market is expected to
expand at a CAGR of 8.1% from 2021 to 2028 with an increasing approval for laser-based therapy to treat driving growth.
REGEN FACTOR
Australia-based Progressive R&D skin biology company
ReGen Factor is an Australia-based progressive R&D skin biology company with a global reach. ReGen Factor has developed first-to-market technology to produce bio-identical and cost-effective Fibroblast growth factors (FGFs), which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation.
We are making a global impact in the cosmetic, cosmeceutical, and pharmaceutical industries with a firm commitment to technology and innovation and our expertise in bio-identical, cost-effective fibroblast growth factors.
PEPFACTOR
PepFactor is an advanced skin and scalp rejuvenation treatment formulated by doctors and scientists which is designed to stimulate the body’s own synthesis of natural fibroblast in the skin to drastically increase collagen and elastin, delivering never seen before results.
PepFactor utilizes the world’s first natural and bio-identical protein to stimulate the body’s skin and scalp for unsurpassed rejuvenation.
PepFactor offers clients an alternative to surgery for glowing, healthy-looking, natural skin rejuvenation and thicker, healthier-looking hair for both men and women.
OUR SCIENCE (Tech and Stats)
- proprietary production method
ReGen Factor uses our proprietary production method to create the world’s first authentic bio-identical fibroblast growth factor for use in our products.
- PepFactor is 98%
With an amino acid sequence identical to our natural Basic Fibroblast Growth Factor (bFGF) structure, PepFactor is 98% pure and encourages the body’s natural stimulation of biological functions.
- best results at an affordable price
ReGen Factor uses its novel production technology to ensure its growth factors are affordable and have high efficacy, purity, and stability for the best results at an affordable price.
WHY INVEST
ReGen Factor is an Australia-based progressive R&D skin biology company with a global reach. ReGen Factor has developed first-to-market technology to produce bio-identical and cost-effective Fibroblast growth factors (FGFs), which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation.
We are making a global impact in the cosmetic, cosmeceutical, and pharmaceutical industries with a firm commitment to technology and innovation and our expertise in bio-identical, cost-effective fibroblast growth factors.
DO YOU HAVE ANY QUESTIONS?
PepFactor GROWTH PIPELINES
PepFactor SALES PIPELINE
PEPFACTOR COSMETIC SALES
PEPFACTOR DISTRIBUTION
TRADEMARK REGISTRATIONS
DEVELOPMENT PATENT
Patent for ReGen Factors uniguee development method have been processed
CE MARK
CE Mark to be submitted for registration of PepFactor for sale in the European Union and the UK
PepFactor FDA APPROVAL PIPELINE
FDA CONSULTANTS
FOA consultants have been appointed to navigate the FDA approval process
PRIMARY INVESTIGATOR
A primary investigator for the phase 1 trial has been appointed
TRIAL DESIGN AND PLANNING
Trial design and planning is underway
PRE-IND MEETING
Preparations are being made for a Pre-IND meeting to be held H2 2021
PHASE 1 TRIAL
Phase1 Clinical Trial to Commence 2022
SCHEDULE YOUR
FREE CONSULTATION NOW!
RECENT NEWS
Quarterly Update
Welcome to ReGen Factor’s latest quarterly update. Since our last update in May, yourcompany has been working hard to progress our goals of FDA approval
Appointment of New Distributor Dubai
Sydney, AUSTRALIA., August 02, 2022 /PRNewswire/ — ReGen Factor, an international leader in medical and aesthetic devices and PepFactor cosmeceuticals, today announced the expansion of
ReGen Factor expand its distribution network to the UK with the addition of its distribution partner MedSpa Equip UK
NEWS PROVIDED BY ReGen Factor Pty Ltd August 02, 2022, 22:01 GMT SHARE THIS ARTICLE ReGen Factor and MedSpa Equip UK have partnered to expand